Venator Sells Iron Oxide Pigments to Cathay Industries

US titanium dioxide pigments and performance additives producer Venator Materials has agreed to sell its iron oxide business to Hong Kong’s Cathay Industries for an enterprise value of $140 million. The transaction is expected to close by the end of quarter one 2023.

Venator said Cathay, which regards itself as a leading global iron oxide pigment manufacturer, “will be an excellent long-term strategic owner of the business going forward.”

“The acquisition of Venator’s iron oxide pigment operation transforms our global manufacturing footprint, providing tremendous synergies and new growth opportunities,” said Terence Yu, CEO of Cathay Industries Group.

Cathay added that the Venator business has achieved steady growth and maintained profitability amid the pandemic and market fluctuations, demonstrating strong competitiveness and resilience.

The average EBITDA of the iron oxide business in 2020 and 2021 pro forma and adjusted for the impact of a sale leaseback was $16 million. Venator closed a sale-leaseback transaction for its Color Pigments manufacturing facility in Los Angeles, California for $51 million on Oct. 7.

In addition to Venator’s product portfolio, the purchase includes eight manufacturing sites and one administrative site, across six countries on four continents.

© Sashkin/Shutterstock
© Sashkin/Shutterstock

Announcing its third-quarter results, which saw the group’s net loss widen to $50 million compared with $47 million in the same period last year, Venator said it has implemented a range of measures that include cutting costs, which should deliver $50 million in annualized savings by the end of 2024.

Venator president and CEO Simon Turner added that the group’s priorities are “focused on cost reduction, improvement of our liquidity profile and optimization of our manufacturing network.”

Author: Elaine Burridge, Freelance Journalist

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.